Literature DB >> 18814498

A data capture system for outcomes studies that integrates with electronic health records: development and potential uses.

Keiichi Yamamoto1, Shigemi Matsumoto, Harue Tada, Kazuhiro Yanagihara, Satoshi Teramukai, Tadamasa Takemura, Masanori Fukushima.   

Abstract

In conventional clinical studies, the costs of data management for quality control tend to be high and collecting paper-based case report forms (CRFs) tends to be burdensome, because paper-based CRFs must be developed and filled out for each clinical study protocol. Use of electronic health records for this purpose could result in reductions in cost and improvements in data quality in clinical studies. The purpose of this study was to develop a data capture system for observational cancer clinical studies (i.e. outcomes studies) that would integrate with an electronic health records system, to enable evaluation of patient prognosis, prognostic factors, outcomes and drug safety. At the Outpatient Oncology Unit of Kyoto University Hospital, we developed a data capture system that includes a cancer clinical database system and a data warehouse for outcomes studies. We expect that our new system will reduce the costs of data management and analysis and improve the quality of data in clinical studies.

Entities:  

Mesh:

Year:  2008        PMID: 18814498     DOI: 10.1007/s10916-008-9147-7

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  3 in total

1.  Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy.

Authors:  Toshiyuki Kitano; Harue Tada; Tsutomu Nishimura; Satoshi Teramukai; Masashi Kanai; Takafumi Nishimura; Akiko Misawa; Kiyotsugu Yoshikawa; Hiroyasu Yasuda; Hiroshi Ishiguro; Shigemi Matsumoto; Kazuhiro Yanagihara; Masanori Fukushima
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

2.  Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper.

Authors:  Charles Safran; Meryl Bloomrosen; W Edward Hammond; Steven Labkoff; Suzanne Markel-Fox; Paul C Tang; Don E Detmer
Journal:  J Am Med Inform Assoc       Date:  2006-10-31       Impact factor: 4.497

3.  Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures.

Authors:  Tsutomu Nishimura; Harue Tada; Masatsugu Nakagawa; Satoshi Teramukai; Shigeyuki Matsui; Masanori Fukushima
Journal:  Pharm Pract (Granada)       Date:  2006-10
  3 in total
  5 in total

1.  Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer.

Authors:  Shiro Tanaka; Kazuhiro Yanagihara; Satoshi Tamaru; Satoshi Teramukai; Toshiyuki Kitano; Masanori Fukushima
Journal:  Int J Clin Oncol       Date:  2011-11-10       Impact factor: 3.402

2.  Design and evaluation of a service oriented architecture for paperless ICU tarification.

Authors:  Kristof Steurbaut; Kirsten Colpaert; Sofie Van Hoecke; Sabrina Steurbaut; Chris Danneels; Johan Decruyenaere; Filip De Turck
Journal:  J Med Syst       Date:  2010-10-05       Impact factor: 4.460

3.  Electronic hand-drafting and picture management system.

Authors:  Tsung-Han Yang; Cheng-Yuan Ku; David C Yen; Wen-Huai Hsieh
Journal:  J Med Syst       Date:  2011-04-14       Impact factor: 4.460

4.  Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan.

Authors:  Hiroki Nagai; Shiro Tanaka; Miyuki Niimi; Nanae Seo; Takahiko Sasaki; Hiroshi Date; Michiaki Mishima; Hiroyasu Yasuda; Kazuhiro Yanagihara
Journal:  Int J Clin Oncol       Date:  2011-04-06       Impact factor: 3.402

5.  A pragmatic method for electronic medical record-based observational studies: developing an electronic medical records retrieval system for clinical research.

Authors:  Keiichi Yamamoto; Eriko Sumi; Toru Yamazaki; Keita Asai; Masashi Yamori; Satoshi Teramukai; Kazuhisa Bessho; Masayuki Yokode; Masanori Fukushima
Journal:  BMJ Open       Date:  2012-10-31       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.